Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Up 796.7% in August

Fresenius SE & Co. (OTCMKTS:FSNUY) was the recipient of a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 1,029,832 shares, an increase of 796.7% from the July 30th total of 114,842 shares. Based on an average daily volume of 420,053 shares, the days-to-cover ratio is presently 2.5 days. Currently, 0.0% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on FSNUY. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a research report on Thursday, August 6th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

Fresenius SE & Co. Stock Down 0.6%

Shares of OTCMKTS FSNUY traded down $0.08 during midday trading on Tuesday, reaching $13.39. 58,204 shares of the company’s stock were exchanged, compared to its average volume of 155,321. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.98 and a current ratio of 1.27. Fresenius SE & Co. has a 52-week low of $10.33 and a 52-week high of $33.93. The business’s fifty day moving average price is $12.53 and its two-hundred day moving average price is $12.70. The stock has a market capitalization of $30.17 billion, a PE ratio of 16.95 and a beta of 0.61.

Fresenius SE & Co. (OTCMKTS:FSNUY) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The company had revenue of $6.91 billion during the quarter, compared to the consensus estimate of $6.65 billion. Fresenius SE & Co. had a return on equity of 10.33% and a net margin of 6.67%. Analysts forecast that Fresenius SE & Co. will post 1.08 EPS for the current year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.